ClinicalTrials.govpublic full text
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
hiv, hiv infections, hiv-1 infected, treatment experienced, treatment naive, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008495
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.